10 baseline predictors for achieving treatment response to Secukinumab in the EuroSpA study. Having non-radiographic dis
Tweet Content
10 baseline predictors for achieving treatment response to Secukinumab in the EuroSpA study. Having non-radiographic disease was a negative predictor of obtaining LDA at 6 months and remaining on treatment at 12 months in European axSpA patients initiating secukinumab.… https://t.co/HrRnoDzSPP https://t.co/Gp1KZmPych
Links
Show on Archive Page
On
Display in Search Results
On
PDQ
Off